Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective progesterone receptor modulators for treatment of premenstrual dysphoric disorder
2016-001719-19Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Premenstrual Dysphoric Disorder (PMDD) comparing Esmya with Placebo (2 arms). Primary endpoint: DRSP symptom score change. Started Jun 2016; status: completed.
02
Drugs
ulipristal
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on 2016-001719-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001719-19.